Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Receives More than 100 Systems Orders Tied to Stimulus Programs

NEW YORK (GenomeWeb News) – Bruker today said that it has already received more than 100 systems orders associated with various global stimulus funding programs.

The firm said that all five of its operating divisions have received stimulus orders for instruments such as mass spectrometry, NMR, pre-clinical MRI, and X-ray. Bruker estimated the average selling prices of these orders were greater than $500,000 per system — and the total amount of stimulus orders it received in the second half of 2009 exceeded $70 million.

The Billerica, Mass.-based firm said that revenues from these orders would be recorded primarily in 2010 and into the first half of 2011. It also expects to receive additional orders from global stimulus programs during this year.

In September, Bruker said that global stimulus programs could contribute 5 percent — roughly $50 million — or greater revenue growth its core scientific business instruments business in 2010.

In early Thursday trade on the Nasdaq, shares of Bruker were up 2 percent at $13.35.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.